Robin Washington is listed as a director on 11 SEC Form D filings by 3 issuers between Aug 2014 and Feb 2025: SALESFORCE.COM, INC. (San Francisco, CA — other technology — 2014–2019; $666.2M reported sold to 98 investors), Eikon Therapeutics, Inc. (Hayward, CA — biotechnology — 2023–2025; $517.8M reported sold to 43 investors) and Lightmatter, Inc. (Mountain View, CA — other technology — 2024; $350M reported sold to 43 investors).
What this means A repeat sponsor — 3 separate companies raised money with this person listed as director, over about 11 years. Across those companies the filings report $1.53B sold in total.
Listed alongside Alan Hassenfeld (8 shared filings), Alexandre Dayon (8 shared filings), Colin Powell (8 shared filings), Craig Conway (8 shared filings), Joe Allanson (8 shared filings) and 45 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Robin. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 2 bankruptcy cases matching the name listed in Key records below.
What this means 2 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 11 public filings for Robin Washington and found 4 differences: No amendment in the last 12 months on an offering that may still be open; Robin Washington is written 2 different ways on the filings; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.